| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |